RecruitingNot ApplicableNCT03075917

Validation of an Allergic Rhinitis Control Test in Children


Sponsor

University Hospital, Montpellier

Enrollment

135 participants

Start Date

May 4, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.


Eligibility

Min Age: 5 YearsMax Age: 11 Years

Inclusion Criteria2

  • Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
  • Parents formulated their study participation agreement by signing the consent form.

Exclusion Criteria1

  • Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSelf Questionnaire

self questionnaire for allergic rhinitis control


Locations(6)

CH Louis Pasteur

Bagnols-sur-Cèze, France

Maison de santé de Lasalle

Lasalle, France

CH de MILLAU

Millau, France

Centre (Ctre) Medical Ravas - Malbosc

Montpellier, France

University hospital of Montpellier

Montpellier, France

Hôpital Trousseau,

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03075917


Related Trials